Tellgen

Tellgen Days Payable Outstanding

The Days Payable Outstanding (DPO) of Tellgen (300642.SZ) as of Nov 4, 2026 is 258.93. In the previous year, Days Payable Outstanding (DPO) was 183.14 — a change of 41.39% (higher).

Days Payable Outstanding

258.93

YoY

41.39%

Last updated:

Days Payable Outstanding (DPO) of Tellgen is 2025 258.93 . Days Payable Outstanding (DPO) of Tellgen was 2024 183.14 . It decreases by 41.39% higher compared to the previous year.

The Tellgen Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2018
61.50 CNY
Jan 1, 2019
38.43 CNY
Jan 1, 2020
80.53 CNY
Jan 1, 2021
69.17 CNY
Jan 1, 2022
111.30 CNY
Jan 1, 2023
132.32 CNY
Jan 1, 2024
183.14 CNY
Jan 1, 2025
258.93 CNY
The Tellgen Days Payable Outstanding history
YEARDays Payable OutstandingYoY
258.93+41.39%
183.14+38.40%
132.32+18.88%
111.30+60.91%
69.17-14.10%
80.53+109.53%
38.43-37.51%
61.50+320.90%
14.61-80.78%
76.04-25.71%
102.36-6.04%
108.94—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tellgen Stock analysis

What does Tellgen do? Tellgen Corp develops, manufactures, and markets molecular diagnostic products including immunodiagnostic, molecular diagnostic, and biochemical diagnostic products. Their portfolio features tumor marker detection, HPV nucleic acid testing, autoimmune disease detection, and lung cancer methylation mutation detection products. The company targets healthcare providers and laboratories seeking advanced diagnostic solutions for disease detection and monitoring. Tellgen Corp generates revenue through the sale of these specialized diagnostic products to medical institutions and healthcare facilities. The firm's product lines focus on specific diagnostic needs such as cancer screening and infectious disease testing. Immunodiagnostic products detect antibodies and antigens, molecular diagnostic products analyze genetic material, and biochemical diagnostic products measure metabolic markers. Tellgen Corp sells these products directly to hospitals, clinics, and diagnostic laboratories across China and potentially internationally. Tellgen Corp's revenue streams come from the commercialization of its diagnostic product portfolio. The company's offerings address key healthcare challenges including early cancer detection and infectious disease management. Their products are designed to support clinical decision-making and patient care pathways in medical settings. Tellgen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tellgen stock

Days Payable Outstanding (DPO) of Tellgen is 258.93 in 2025.

Days Payable Outstanding (DPO) of Tellgen changed from 183.14 to 258.93, representing a 41.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Tellgen since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Tellgen with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Tellgen

All Key Metrics — Tellgen